Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
life sciences
national blog main
national top stories
novartis
3
×
biotech
cancer
deals
gene therapy
hemophilia
indiana blog main
indiana top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
achromatopsia
administration
alzheimer's
amgen
avapritinib
bellicum pharmaceuticals
beta-thalassemia
bill cassidy
biogen
biomarin pharmaceutical
biontech
bluebird bio
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
breakpoint therapeutics
cancer drugs
capmatinib
car-t
celgene
celyad
clinical trials
What
therapy
3
×
gene
address
age
approval
approves
becker
bigger
biggest
billions
bio
blueprint
cancer
carries
certain
come
deal
designed
dollars
drug
eaton
emerging
fda
gave
genetic
healthcare
impact
j
johnson
latest
life
medicines
meiragtx
michael
millions
morning
moves
pass
past
patients
Language
unset
Current search:
novartis
×
therapy
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy